ABCC8抗體 返回列表頁

ABCC8抗體

抗原
ATP-Binding Cassette, Sub-Family C (CFTR/MRP), Member 8 (ABCC8)
別名 ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, SUR1delta2, TNDM2, D930031B21Rik, Sur, Sur1
適用
其他選擇 Human
Rat ((Rattus))(36),Human (30),Murine (18),Dog (Canine) (13),Guinea Pig (12),Pig (Porcine) (12),Hamster (2),Mammalian (2),Bovine (1)
宿主
其他選擇 Rabbit
Mouse(30),Rabbit (20),Goat (4)
克隆類型
多克隆
標(biāo)記
其他選擇 非結(jié)合性
Biotin(3),FITC (3),HRP (2),APC (1),Alexa Fluor 350 (1),Alexa Fluor 488 (1),Alexa Fluor 555 (1),Alexa Fluor 647 (1),Alkaline Phosphatase (AP) (1),Atto 390 (1),Atto 488 (1),Atto 565 (1),Atto 594 (1),Atto 633 (1),Atto 655 (1),Atto 680 (1),Atto 700 (1),Cy3 (1),Cy5 (1),Cy5.5 (1),Cy7 (1),PE (1),PE-Atto 594 (1),PerCP (1),Streptavidin (1)
應(yīng)用范圍
其他選擇 Dot Blot (DB), Enzyme Immunoassay (EIA), Western Blotting (WB)
Western Blotting (WB)(42),Immunohistochemistry (IHC) (26),Immunocytochemistry (ICC) (19),Immunofluorescence (Paraffin-embedded Sections) (IF (p)) (10),ELISA (9),Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (4),Immunostaining (IS) (2),Enzyme Immunoassay (EIA) (1),Immunoassay (IA) (1)
[Pubmed] 3 references available
規(guī)格 0.1 mg
發(fā)貨至 中國(guó) (更改)
發(fā)貨時(shí)間 29至35個(gè)工作日

ABCC8抗體

產(chǎn)品細(xì)節(jié)

引用 貯存及處理 使用細(xì)節(jié) 目標(biāo)詳細(xì)情況 回頁首

產(chǎn)品細(xì)節(jié)

顯示 隱藏
免疫原 This SUR1 antibody was generated in Rabbits against unique epitope that reside on the surface of the protein.
亞型 IgG
特異性 Sulfonylurea Receptor 1 (ABCC8/SUR1)
交叉反應(yīng) （詳細(xì)） Species reactivity (tested):Human.
純化方法 Affinity Chromatography on immobilized antigen

目標(biāo)詳細(xì)情況

引用 貯存及處理 使用細(xì)節(jié) 回頁首

目標(biāo)詳細(xì)情況

顯示 隱藏
別名 ABCC8
背景 The relation ship between glucose metabolism and insulin secretion from the pancreatic beta cells is linked with ATP-sensitive potassium channels (KATP). IN response to glucose metabolism, the ATP-sensitive potassium channels are inactivated due to an increase in ATP/ADP ratio, resulting in membrane depolarization and calcium influx through voltage dependent L-type Ca+2 channels. The KATPs are composed 4?units of inwardly rectifying K channel subunit (Kir6.2) and 4 copies of regulatory subunit SUR1 in an octameric complex. SUR 1 is a member of ATP binding cassette super family. SUR receptor confers the sensitivity of Kir6.2 to ATP/ADP sensitivity and to pharmacological agents such as sulfonylurea and diazoxide that close or open the KATP channels. The persistent heyperinsulinimic hypoglycemia in infancy (PHHI) is familial disorder due to defect in negative feed back in response to low glucose levels. SUR1 was mapped on chromosome 11p14-15.1, the same location where the gene for PHHI is located (1). It has been shown that the expression of Kir6.2 and SUR1 are regulated by glucose levels and the actives of glucogon-like peptide receptor1 (2). Abnormal insulin secretion in PHHI appears to be caused by mutations in the SUR gene. SUR1 is a 1581 amino acid protein with an ATP binding domain with two nucleotide-binding folds (NBFs) and binding sites for sulfonylureas, like glibenclamide, and for channel openers. SUR contains three hydrophobic domains, TM(0), TM(1), and TM(2), with nucleotide binding folds following TM(1) and TM(2). The protein is glycosylated at position 10 on Asn. The SUR1 gene is expressed in at least 4 multiple splice variants ere are multiple splice variants, these splice variants originate from the splicing of the coding region of NFB and lack of axon 17 (SUR1Delta17), axon 19 (SUR1Delta 19) and both (SUR1Delta 17/19) and the fourth is a COOH terminal fragment formed by Exxon 31-39 containing the last 2 TMD and the COOH terminal (SUR1C). The various splice variants of SUR1 are expressed in various tissues with strong expression of SUR1C in cardiomyocytes (3). Only SUR1 and SUR1Delta 17 exhibit high affinity binding sites for sulfonylurea and other pharmacological agents. Several point mutations in the NFB region of SUR1 are also described in NIDDM. A total of five amino acid substitutions and 17 silent mutations were noted by examining all 39 axons of this gene in NIDDM patients form Japan. Two rare novel mutations, D811N in axon 20 and R835C in axon 21, were identified in the first nucleotide-binding fold (NBF), a functionally important region of SUR1, in one patient each, both heterozygotes.Synonyms: ATP-binding cassette transporter sub-family C member 8, HRINS, SUR, SUR1, Sulfonylurea receptor 1
分子量 115-120 kDa.
基因ID 6833
NCBI Accession NP_000343
UniProt Q09428

使用細(xì)節(jié)

引用 貯存及處理 目標(biāo)詳細(xì)情況 回頁首

使用細(xì)節(jié)

顯示 隱藏
應(yīng)用備注 This antibody is ideal for ELISA (1/10,000-1/100,000), Dot blot and Western Blot (1/500).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
限制 For Research Use only

貯存及處理

引用 使用細(xì)節(jié) 目標(biāo)詳細(xì)情況 回頁首

貯存及處理

顯示 隱藏
濃度 0.52-0.98 mg/mL
緩沖液 Stabilization buffer
注意事項(xiàng) Avoid repeated freezing and thawing.
儲(chǔ)存條件 -20 °C
儲(chǔ)存方法 Store the antibody undiluted (in aliquots) at-20 °C.

xy-5833R Cornulin熱休克蛋白58抗體
xy-6695R Cytochrome P450 17A1細(xì)胞色素C P450 17A1抗體
xy-6683R CLDND1膜蛋白CLDND1抗體
xy-6652R CRMP1二氫嘧啶酶相關(guān)蛋白1抗體
xym-4541M Chloramphenicol氯霉素單克隆抗體
xy-6659R CD98CD98重鏈抗原抗體
xy-6701R Calpastatin鈣蛋白酶抑制蛋白抗體
xy-6705R cGKIcGMP依賴性蛋白激酶1抗體
xy-6709R CaIPLA2胞漿鈣獨(dú)立磷脂酶A2抗體
xy-15082R C1orf98 1號(hào)染色體開放閱讀框98抗體
xy-8310R COX4NBCOX4NB蛋白抗體
xy-8331R CPXCR1腫瘤/睪丸抗原77抗體
xy-6934R CD81CD81抗體
xy-11656R COQ10B輔酶Q10B抗體
xy-8663R CRLF1細(xì)胞因子受體樣因子1抗體
xy-11822R CSAD半胱氨酸亞磺酸脫羧酶抗體
xy-6407R CHCHD2丙型肝炎NS2反式調(diào)節(jié)蛋白/衰老相關(guān)的基因10蛋白抗體
xy-6436R CYP11B2醛固酮合成酶CYP11B2抗體
xy-7834R CDCA8細(xì)胞分裂周期蛋白8抗體
xy-6908R CCDC5卷曲螺旋結(jié)構(gòu)域蛋白5抗體
xy-7832R CDC16細(xì)胞分裂周期蛋白16抗體
xy-7839R CENPF有絲分裂著絲粒蛋白F抗體
xy-15309R C9orf1159號(hào)染色體開放閱讀框115抗體
xy-8241R CTDSPLCTDSPL蛋白抗體
xy-8242R CTDSPL2CTDSPL2蛋白抗體
xy-8248R CUTA乙酰膽堿酯酶相關(guān)蛋白抗體
xy-8139R CCDC83卷曲螺旋結(jié)構(gòu)域蛋白83抗體
xy-8283R CRMP5二氫嘧啶酶相關(guān)蛋白5抗體